• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素处理的BEL-7404人肝癌细胞中的端粒酶抑制和端粒丢失

Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin.

作者信息

Zhang Ru-Gang, Guo Li-Xia, Wang Xing-Wang, Xie Hong

机构信息

Department of Biotherapy, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, the Chinese Academy of Sciences, Shanghai 200031, China.

出版信息

World J Gastroenterol. 2002 Oct;8(5):827-31. doi: 10.3748/wjg.v8.i5.827.

DOI:10.3748/wjg.v8.i5.827
PMID:12378624
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4656569/
Abstract

AIM

To study the effects of doxorubicin on telomerase activity and telomere length in hepatocellular carcinoma.

METHODS

Telomerase activity was assayed with a non-radioisotopic quantitative telomerase repeat amplification protocol-based method. The effect of doxorubicin (DOX) on the growth of BEL-7404 human hepatoma cells was determined by microculture tetrazolium assay. Mean telomere length (terminal restriction fragment) was detected by Southern blot method. The expression of telomerase subunits genes was investigated by RT-PCR. Cell apoptosis and cell cycle distribution were evaluated by flow cytometry.

RESULTS

Telomerase activity was inhibited in a dose and time-dependent manner in BEL-7404 human hepatoma cells treated with DOX for 24, 48 or 72 h in concentrations from 0.156 to 2.5 microM which was correlated with the inhibition of cell growth. No changes were found in the mRNA expression of three telomerase subunits (hTERT, hTR and TP1) after drug exposure for 72 h with indicated concentrations. The cells treated with DOX showed shortened mean telomere length and accumulated at the G(2)/M phase. However, there was almost no effects on cell apoptosis by DOX.

CONCLUSION

The telomerase inhibition and the telomere shortening by DOX may contribute to its efficiency in the treatment in hepatocellular carcinoma.

摘要

目的

研究阿霉素对肝癌细胞端粒酶活性及端粒长度的影响。

方法

采用基于非放射性定量端粒酶重复序列扩增法检测端粒酶活性。用微量培养四氮唑蓝法测定阿霉素(DOX)对人肝癌BEL-7404细胞生长的影响。采用Southern印迹法检测平均端粒长度(末端限制片段)。通过逆转录聚合酶链反应研究端粒酶亚基基因的表达。用流式细胞术评估细胞凋亡和细胞周期分布。

结果

用浓度为0.156至2.5微摩尔的DOX处理人肝癌BEL-7404细胞24、48或72小时,端粒酶活性呈剂量和时间依赖性抑制,这与细胞生长抑制相关。在指定浓度下用药物处理72小时后,三种端粒酶亚基(hTERT、hTR和TP1)的mRNA表达未发现变化。用DOX处理的细胞平均端粒长度缩短,并在G(2)/M期积累。然而,DOX对细胞凋亡几乎没有影响。

结论

DOX抑制端粒酶活性和缩短端粒长度可能有助于其治疗肝癌的疗效。

相似文献

1
Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin.阿霉素处理的BEL-7404人肝癌细胞中的端粒酶抑制和端粒丢失
World J Gastroenterol. 2002 Oct;8(5):827-31. doi: 10.3748/wjg.v8.i5.827.
2
Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells.顺铂对人肝癌BEL-7404细胞端粒酶活性及端粒长度的影响
Cell Res. 2002 Mar;12(1):55-62. doi: 10.1038/sj.cr.7290110.
3
Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.端粒酶拮抗剂GRN163和GRN163L抑制肿瘤生长并增强人肝癌的化疗敏感性。
Hepatology. 2005 Nov;42(5):1127-36. doi: 10.1002/hep.20822.
4
Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.人卵巢癌细胞中抗癌药物化学敏感性与端粒长度、端粒酶活性及端粒酶RNA表达的相关性
Anticancer Res. 2000 Jan-Feb;20(1A):203-12.
5
Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.人肝癌细胞端粒酶活性的抑制及其RNA组分反义寡脱氧核糖核苷酸对细胞周期的调控
Acta Pharmacol Sin. 2000 Aug;21(8):742-6.
6
A novel telomere elongation in an adriamycin-resistant stomach cancer cell line with decreased telomerase activity.一种端粒酶活性降低的阿霉素耐药胃癌细胞系中的新型端粒延长现象。
Mol Cells. 2002 Apr 30;13(2):228-36.
7
Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.反义人端粒酶逆转录酶可在体外部分逆转胃癌细胞系的恶性表型。
Eur J Cancer Prev. 2008 Jun;17(3):209-17. doi: 10.1097/CEJ.0b013e3282b71f0d.
8
HIV-Tat-mediated delivery of an LPTS functional fragment inhibits telomerase activity and tumorigenicity of hepatoma cells.HIV-Tat 介导的 LPTS 功能片段的递呈抑制肝癌细胞的端粒酶活性和致瘤性。
Gastroenterology. 2011 Jan;140(1):332-43. doi: 10.1053/j.gastro.2010.08.046. Epub 2010 Nov 20.
9
Distinct modulation of telomere length in two T-lymphoblastic leukemia cell lines by cytotoxic nucleoside phosphonates PMEG and PMEDAP.细胞毒性核苷膦酸 PMEG 和 PMEDAP 对两种 T 淋巴细胞白血病细胞系端粒长度的不同调节。
Eur J Pharmacol. 2010 Sep 15;643(1):6-12. doi: 10.1016/j.ejphar.2010.06.006. Epub 2010 Jun 22.
10
Telomere and telomerase in the initial stage of immortalization of esophageal epithelial cell.食管上皮细胞永生化初期的端粒与端粒酶
World J Gastroenterol. 2002 Apr;8(2):357-62. doi: 10.3748/wjg.v8.i2.357.

引用本文的文献

1
SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma.SMG6在Hippo信号通路激酶LATS2失活的恶性间皮瘤中调节DNA损伤和细胞存活。
Cell Death Discov. 2022 Nov 5;8(1):446. doi: 10.1038/s41420-022-01232-w.
2
Influence of Amalaki Rasayana on telomerase activity and telomere length in human blood mononuclear cells.阿马拉吉·拉萨亚纳对人血单核细胞端粒酶活性和端粒长度的影响。
J Ayurveda Integr Med. 2017 Apr-Jun;8(2):105-112. doi: 10.1016/j.jaim.2017.01.007. Epub 2017 Jun 9.
3
Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma.食管鳞状细胞癌中人类端粒酶亚基表达与端粒酶活性的相关性
World J Gastroenterol. 2003 Nov;9(11):2395-9. doi: 10.3748/wjg.v9.i11.2395.

本文引用的文献

1
Antihepatoma effect of alpha-fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice.甲胎蛋白反义硫代磷酸酯寡脱氧核糖核苷酸在体外及小鼠体内的抗肝癌作用
World J Gastroenterol. 2001 Jun;7(3):345-51. doi: 10.3748/wjg.v7.i3.345.
2
Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.紫杉醇对人肝癌的体外及裸鼠体内生长抑制作用。
World J Gastroenterol. 2000 Apr;6(2):210-215. doi: 10.3748/wjg.v6.i2.210.
3
Telomere, telomerase and digestive cancer.端粒、端粒酶与消化系统癌症
World J Gastroenterol. 1999 Aug;5(4):334-337. doi: 10.3748/wjg.v5.i4.334.
4
Telomerase activity in gastric cancer and its clinical implications.胃癌中的端粒酶活性及其临床意义。
World J Gastroenterol. 1999 Aug;5(4):316-319. doi: 10.3748/wjg.v5.i4.316.
5
Down-regulation of Hsp90 could change cell cycle distribution and increase drug sensitivity of tumor cells.热休克蛋白90(Hsp90)的下调可改变细胞周期分布并增加肿瘤细胞的药物敏感性。
World J Gastroenterol. 1999 Jun;5(3):199-208. doi: 10.3748/wjg.v5.i3.199.
6
Presence of Fas and Bcl-2 proteins in BEL-7404 human hepatoma cells.Fas和Bcl-2蛋白在人肝癌细胞BEL-7404中的表达情况。
World J Gastroenterol. 1998 Dec;4(6):540-543. doi: 10.3748/wjg.v4.i6.540.
7
Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase.突变型端粒酶逆转录酶的表达对人肝癌BEL-7404细胞生长的抑制作用
Int J Cancer. 2002 Jan 10;97(2):173-9. doi: 10.1002/ijc.1597.
8
Human hepatoma cell telomerase activity inhibition and cell cycle modulation by its RNA component antisense oligodeoxyribonucleotides.人肝癌细胞端粒酶活性的抑制及其RNA组分反义寡脱氧核糖核苷酸对细胞周期的调控
Acta Pharmacol Sin. 2000 Aug;21(8):742-6.
9
Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development.人类端粒酶逆转录酶(hTERT)的组织特异性可变剪接在人类发育过程中影响端粒长度。
Int J Cancer. 2001 Mar 1;91(5):644-9.
10
Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line.在鳞状细胞癌细胞系中,抑制端粒酶活性作为顺铂杀伤肿瘤细胞的一种衡量指标。
Chemotherapy. 2001 Mar-Apr;47(2):136-42. doi: 10.1159/000048513.